Aortic Valve Regurgitation: A Comprehensive Review

Curr Probl Cardiol. 2018 Aug;43(8):315-334. doi: 10.1016/j.cpcardiol.2017.10.004. Epub 2017 Nov 2.

Abstract

Aortic regurgitation (AR) has an estimated prevalence of 4.9% in the Framingham study, with moderate or severe AR occurring in 0.5% of the study population. The incidence and severity of AR increases with age, and may occur acutely or as a chronic valvular disease with distinct presentations, natural history and management strategy. Our review is a comprehensive description of the varied presentation of aortic regurgitation and its management.

Publication types

  • Review

MeSH terms

  • Aortic Valve Insufficiency* / diagnosis
  • Aortic Valve Insufficiency* / epidemiology
  • Aortic Valve Insufficiency* / physiopathology
  • Aortic Valve Insufficiency* / therapy
  • Aortic Valve* / drug effects
  • Aortic Valve* / physiopathology
  • Aortic Valve* / surgery
  • Cardiovascular Agents / therapeutic use
  • Heart Valve Prosthesis Implantation
  • Hemodynamics
  • Humans
  • Incidence
  • Predictive Value of Tests
  • Risk Factors
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Cardiovascular Agents